Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Qiagen NV (NYSE: QGEN) closed at $45.56 down -0.65% from its previous closing price of $45.86. In other words, the price has decreased by -$0.65 from its previous closing price. On the day, 0.86 million shares were traded. QGEN stock price reached its highest trading level at $46.18 during the session, while it also had its lowest trading level at $45.545.
Ratios:
For a deeper understanding of Qiagen NV’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.63. For the most recent quarter (mrq), Quick Ratio is recorded 2.30 and its Current Ratio is at 2.60. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.45.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on June 24, 2025, initiated with a Overweight rating and assigned the stock a target price of $55.
Robert W. Baird Downgraded its Outperform to Neutral on February 19, 2025, whereas the target price for the stock was revised from $52 to $42.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 15 ’25 when Thierry Bernard bought 25,000 shares for $48.80 per share.
ROLAND SACKERS bought 31,423 shares of QGEN for $1,546,257 on Aug 15 ’25. On Aug 14 ’25, another insider, ROLAND SACKERS, who serves as the Officer of the company, bought 18,577 shares for $49.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QGEN now has a Market Capitalization of 9879275520 and an Enterprise Value of 10659994624. As of this moment, Qiagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.58, and their Forward P/E ratio for the next fiscal year is 18.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.77 while its Price-to-Book (P/B) ratio in mrq is 2.71. Its current Enterprise Value per Revenue stands at 5.148 whereas that against EBITDA is 10.477.
Stock Price History:
The Beta on a monthly basis for QGEN is 0.67, which has changed by -0.0064991117 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, QGEN has reached a high of $51.88, while it has fallen to a 52-week low of $37.63. The 50-Day Moving Average of the stock is -1.99%, while the 200-Day Moving Average is calculated to be 1.00%.
Shares Statistics:
For the past three months, QGEN has traded an average of 1.18M shares per day and 1224540 over the past ten days. A total of 216.84M shares are outstanding, with a floating share count of 215.78M. Insiders hold about 0.49% of the company’s shares, while institutions hold 76.18% stake in the company. Shares short for QGEN as of 1763078400 were 6164497 with a Short Ratio of 5.24, compared to 1760486400 on 6005547. Therefore, it implies a Short% of Shares Outstanding of 6164497 and a Short% of Float of 4.22.
Dividends & Splits
According to the company, the forward annual dividend rate for QGEN is 0.25, from 0.25 in the trailing year. Against a Trailing Annual Dividend Yield of 0.0054513738. The current Payout Ratio is 0.00% for QGEN, which recently paid a dividend on 2025-07-02 with an ex-dividend date of 2025-07-02. Stock splits for the company last occurred on 2017-01-25 when the company split stock in a 962:1000 ratio.
Earnings Estimates
. The current assessment of Qiagen NV (QGEN) involves the perspectives of 11.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.58, with high estimates of $0.6 and low estimates of $0.55.
Analysts are recommending an EPS of between $2.76 and $2.33 for the fiscal current year, implying an average EPS of $2.38. EPS for the following year is $2.54, with 16.0 analysts recommending between $2.96 and $2.41.
Revenue Estimates
A total of 10 analysts believe the company’s revenue will be $528.8M this quarter.It ranges from a high estimate of $532.06M to a low estimate of $527M. As of. The current estimate, Qiagen NV’s year-ago sales were $521.2MFor the next quarter, 10 analysts are estimating revenue of $510.39M. There is a high estimate of $517.2M for the next quarter, whereas the lowest estimate is $499M.
A total of 17 analysts have provided revenue estimates for QGEN’s current fiscal year. The highest revenue estimate was $2.1B, while the lowest revenue estimate was $2.04B, resulting in an average revenue estimate of $2.08B. In the same quarter a year ago, actual revenue was $1.98BBased on 17 analysts’ estimates, the company’s revenue will be $2.2B in the next fiscal year. The high estimate is $2.25B and the low estimate is $2.16B.
